SYNERGY SPINAL SYSTEM SEE ATTACHMENT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2005-06-30 for SYNERGY SPINAL SYSTEM SEE ATTACHMENT manufactured by Interpore Cross Intl..

Event Text Entries

[16149639] Difficulties were experienced during surgery, as screws would not seat properly onto the seat. Excess force was applied in order to assemble the implants together. There was no pt harm or injury and the case was completed unventfully.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2029012-2005-00032
MDR Report Key618635
Report Source05,07
Date Received2005-06-30
Date of Report2005-06-30
Date of Event2005-06-02
Date Added to Maude2005-07-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactMARY CARVAJAL
Manufacturer Street181 TECHNOLOGY DR
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone9494533200
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSYNERGY SPINAL SYSTEM
Generic NameORTHOPEDIC IMPLANT
Product CodeJDK
Date Received2005-06-30
Model NumberNA
Catalog NumberSEE ATTACHMENT
Lot NumberSEE ATTACHMENT
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagY
Date Removed*
Device Sequence No1
Device Event Key608322
ManufacturerINTERPORE CROSS INTL.
Manufacturer Address* IRVINE CA * US
Baseline Brand NameBIOPLEX C IMPLANT
Baseline Generic NameCEMENT RESTRICTOR
Baseline Model NoNA
Baseline Catalog NoSEE ATTACHMENT
Baseline IDNA
Baseline Device FamilySEE ATTACHMENT
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]24
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK023908
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other; 2. Required No Informationntervention 2005-06-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.